Unexplained weight loss (UWL), defined as a reduction of body weight unintentionally, is a common clinical problem that often poses a diagnostic challenge to physicians. While it can be a symptom of numerous underlying conditions, the key to an accurate diagnosis lies in a comprehensive, systematic approach.
The initial evaluation should involve a detailed patient history and physical examination. Inquiring about the time frame and magnitude of weight loss, associated symptoms, and dietary and lifestyle changes can provide valuable clues. The physical examination should focus on signs of malnutrition or systemic diseases.
Basic laboratory tests can help identify potential causes of UWL. A complete blood count, metabolic panel, thyroid function tests, and urinalysis are usually recommended. Additional tests, such as tumor markers or imaging studies, may be necessary based on the patient's history and physical findings.
Imaging plays a crucial role in diagnosing UWL when the cause is not evident from history, physical examination, and basic laboratory tests. CT scans, MRI, and PET scans can reveal hidden malignancies, infections, or inflammatory conditions that may contribute to weight loss.
If gastrointestinal causes are suspected, endoscopy and biopsies can help identify conditions such as celiac disease, inflammatory bowel disease, or malignancies. However, these procedures should be reserved for patients with specific symptoms or risk factors.
Diagnosing unexplained weight loss requires a comprehensive and systematic approach. Physicians should not only rely on advanced investigations but also give due importance to a detailed history and physical examination. This approach can help identify the underlying cause, allowing for timely intervention and improved patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation